REGN - Regeneron to vigorously defend against DOJ on Eylea pricing complaint
2024-04-16 08:37:08 ET
More on Regeneron Pharmaceuticals
- Regeneron's Triple Threat: Eylea, Libtayo, And Dupixent Dominate
- Regeneron Pharmaceuticals, Inc. (REGN) Leerink Partners Global Biopharma Conference (Transcript)
- Regeneron Pharmaceuticals, Inc. (REGN) Barclays 26th Annual Global Healthcare Conference (Transcript)
- Regeneron hits three-month low after DOJ complaint; RBC defends
- DOJ files complaint against Regeneron over Eylea Medicare pricing